| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO &Chief Strategy Officer
1 company
Mohindru Mani is a CFO &Chief Strategy Officer at Tvardi Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $73K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2019 | TVRD Tvardi Therapeutics, Inc. | CFO &Chief Strategy Officer | Sell | 4,755 | $17.05 | $81,072.75 | -21.4% | |
| Jul 15, 2019 | TVRD Tvardi Therapeutics, Inc. | CFO &Chief Strategy Officer | Sale+OE | 37,431 | $25.00 | $935,775.00 | -73.0% | |
| May 29, 2019 | TVRD Tvardi Therapeutics, Inc. | CFO &Chief Strategy Officer | Sell | 2,496 | $21.39 | $53,389.44 | -15.3% | |
| Mar 13, 2019 | TVRD Tvardi Therapeutics, Inc. | CFO &Chief Strategy Officer | Sale+OE | 16,041 | $19.12 | $306,703.92 | -66.7% | |
| Dec 28, 2018 | TVRD Tvardi Therapeutics, Inc. | CFO &Chief Strategy Officer | Sell | 4,500 | $12.55 | $56,475.00 | -35.9% | |
| Nov 15, 2018 | TVRD Tvardi Therapeutics, Inc. | CFO &Chief Strategy Officer | Sale+OE | 16,042 | $18.50 | $296,777.00 | -100% | |
| Oct 17, 2018 | TVRD Tvardi Therapeutics, Inc. | CFO &Chief Strategy Officer | Sale+OE | 16,042 | $20.19 | $323,887.98 | -100% |